SRI Logo
An independent, nonprofit research institute

©2010 SRI International
Privacy policy

 

Breast cancer

Late-Stage Breast Cancer Drug Advancing to Clinical Development

SRI is furthering development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd.

More News » | Events »  

Meet Our Innovators

Client-
Sponsored R&D

Intellectual Property and Licensing

Spin-off Ventures

Innovation Partnerships

Timeline of Innovations

Featured
Videos

Connect

Facebook
Twitter
LinkedIn
Youtube

Ken Augustyn, Assistant Director, SRI Ann Arbor

Meeting important needs of government, business, and foundations

Technology transfer for new opportunities

Creating market value

Creating compelling value for organizations and customers

SRI has created new industries, markets, and benefits to society

Some of our latest innovations

Ken Augustyne  Licensing Spin-off partnership first computer mouse